An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma
Clinical trial NCT06379451 · UNKNOWN
Trial details
- NCT number
- NCT06379451
- Sponsor
- Changzhou No.2 People's Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-18
- Primary completion
- 2025-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.